TD Cowen Remains a Buy on Talkspace (TALK)

TD Cowen analyst Charles Rhyee maintained a Buy rating on Talkspace (TALK – Research Report) today and set a price target of $5.00. The company’s shares closed last Friday at $2.81.

Rhyee covers the Healthcare sector, focusing on stocks such as Teladoc, Charles River Labs, and CVS Health. According to TipRanks, Rhyee has an average return of 3.4% and a 48.24% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Talkspace with a $4.00 average price target.

The company has a one-year high of $3.92 and a one-year low of $0.81. Currently, Talkspace has an average volume of 1.55M.

Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TALK in relation to earlier this year. Last month, Steven Dziedzic, the CPO of TALK bought 11,574.00 shares for a total of $10,185.12.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Talkspace (TALK) Company Description:

Talkspace is a behavioral health company offering online therapy. It provides mental health services virtually to its members, including counseling, psychotherapy, and psychiatry through licensed therapists.